NDC 17856-1122-7 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-7
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Extra Strength Pain Reliever | ACETAMINOPHEN TABLETS 500 MG | WALGREENS | c25bfe92-0196-0489-e053-2995a90abea1 | 2025-01-30 | Warnings | M013 362O9ITL9D |
| Low dose Aspirin | ASPIRIN 81 MG DELAYED RELEASE TABLETS | WALGREENS | c25c3524-3e24-3410-e053-2995a90a73ed | 2025-01-30 | Warnings | M013 |
| Extra Strength Nite-Time Pain Relief | 430R WALGREENS ACETAMINOPHEN 500 MG,DIPHENHYDRAMINE HCL 25 MG TABLET | WALGREENS | c25cff5a-93f5-62aa-e053-2a95a90aa7b4 | 2025-01-30 | Warnings | 362O9ITL9D |
| HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | b5a45daa-05b1-4d6d-e053-2995a90a8444 | 2025-01-30 | Warnings | M013 362O9ITL9D |
| NIGHTTIME COLD AND FLU Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | WALGREENS | dbf5c814-4e69-13ac-e053-2a95a90a49a3 | 2025-01-30 | Warnings | 362O9ITL9D |
| Aspirin 81 | ASPIRIN | WALGREENS | d71a571e-e2ce-7e0a-e053-2a95a90a53e0 | 2025-01-30 | Warnings | M013 |
| Regular strength aspirin | ASPIRIN | TARGET CORPORATION | e8c87ccb-8c0c-7830-e053-2995a90a88b7 | 2025-01-30 | Warnings | M013 |
| Sinus Congestion and Pain Relief Non-Drowsy, Daytime | ACETAMINOPHEN AND PHENYLEPHRINE HCL | Rite Aid Corporation | 8a0a8abf-0a41-44f8-8f4f-aec68a0fa0c5 | 2025-01-30 | Warnings | 362O9ITL9D |
| Multi-Symptom Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | TARGET | 2368ac1b-d644-9908-e063-6394a90a4b89 | 2025-01-29 | Warnings | M013 362O9ITL9D |
| Mucinex Childrens Mighty Chews Cold and Flu | ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE | RB Health (US) LLC | 2ce20ab5-5f2d-1c97-e063-6394a90ad67b | 2025-01-29 | Warnings | 362O9ITL9D |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Walgreen Company | 28e275fb-d615-4725-998c-946fe1bfdc0c | 2025-01-29 | Warnings | M013 362O9ITL9D |
| Hydrocodone APAP | HYDROCODONE APAP | Direct_Rx | deaa53c1-81ed-7497-e053-2995a90a07cc | 2025-01-28 | Warnings, Adverse reactions | 362O9ITL9D |
| Childrens Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 38b839b6-de7d-4f33-a19a-efc92cdad92c | 2025-01-24 | Warnings | M013 307668 362O9ITL9D |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | 1Q73Q2JULR | |
| good sense pain relief | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 523b68da-cd2a-4960-95e7-de5d51ce33c1 | 2025-01-23 | Warnings | M013 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Direct_Rx | e78e50c0-36da-528e-e053-2995a90a3d80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Direct_Rx | e8a7c995-e473-ca87-e053-2995a90a5b80 | 2025-01-22 | Warnings, Adverse reactions | 362O9ITL9D |
| HYDROCODONE/APAP | HYDROCODONE/APAP | Direct_Rx | efe3b2eb-5c26-3783-e053-2995a90a6ba8 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Percocet | OXYCODONE/APAP | Direct_Rx | ee151649-b52a-0a51-e053-2a95a90a6c35 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Norco | HYDROCODONE/APAP | Direct_Rx | ee248dfd-7aa7-7dcc-e053-2995a90af19f | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.